These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20649872)

  • 1. Economic evaluation in clinical nephrology: part 2. Applying economic evaluations in clinical nephrology.
    Wong G; Howard K; Craig JC
    Nephrology (Carlton); 2010 Aug; 15(5):533-9. PubMed ID: 20649872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation in clinical nephrology: Part 1. An introduction to conducting an economic evaluation in clinical practice.
    Wong G; Howard K; Craig JC
    Nephrology (Carlton); 2010 Jun; 15(4):434-40. PubMed ID: 20609095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence and values: requirements for public reimbursement of drugs for rare diseases--a case study in oncology.
    Drummond M; Evans B; LeLorier J; Karakiewicz P; Martin D; Tugwell P; MacLeod S
    Can J Clin Pharmacol; 2009; 16(2):e273-81; discussion e282-4. PubMed ID: 19439771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.
    Cosler LE; Lyman GH
    Cancer Invest; 2009 Dec; 27(10):953-9. PubMed ID: 19909009
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cancer of the kidney in adults. Economic aspects].
    Prog Urol; 1997 Nov; 7(5):901-4. PubMed ID: 9458486
    [No Abstract]   [Full Text] [Related]  

  • 6. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical-economic evaluation of lung cancers. Theoretical approaches and practical applications].
    Vergnenegre A; Chouaïd C; Lafuma A
    Rev Mal Respir; 1998 Sep; 15(4):469-78. PubMed ID: 9805757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost, effectiveness, and cost-effectiveness.
    Diamond GA; Kaul S
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):49-54. PubMed ID: 20031812
    [No Abstract]   [Full Text] [Related]  

  • 9. The limits of cost-effectiveness analysis.
    Weintraub WS; Cohen DJ
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):55-8. PubMed ID: 20031813
    [No Abstract]   [Full Text] [Related]  

  • 10. Critical appraisal of published economic evaluations of home care for the elderly.
    Ramos ML; Ferraz MB; Sesso R
    Arch Gerontol Geriatr; 2004; 39(3):255-67. PubMed ID: 15381344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
    Lyman GH
    Cancer Invest; 2009 Jul; 27(6):593-7. PubMed ID: 19557579
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic evaluation of cancer therapies: more and better studies will lead to better choices in cancer care.
    Uyl-de Groot CA
    Eur J Cancer; 2006 Nov; 42(17):2862-6. PubMed ID: 17008095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to read critically a prognostic cohort study.
    Palmer SC; Strippoli GF
    Nephrology (Carlton); 2010 Oct; 15(7):676-82. PubMed ID: 21040162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.
    Graf von der Schulenburg JM; Greiner W; Jost F; Klusen N; Kubin M; Leidl R; Mittendorf T; Rebscher H; Schoeffski O; Vauth C; Volmer T; Wahler S; Wasem J; Weber C;
    Value Health; 2008; 11(4):539-44. PubMed ID: 18194408
    [No Abstract]   [Full Text] [Related]  

  • 15. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [German recommendations for health care economic evaluation studies. Revised version of the Hannover consensus. Hannover Consensus Group].
    Med Klin (Munich); 2000 Jan; 95(1):52-5. PubMed ID: 10668346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parameter of evidence-based medicine in health care economics].
    Wasem J; Siebert U
    Z Arztl Fortbild Qualitatssich; 1999 Aug; 93(6):427-36. PubMed ID: 10519192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic reviews of economic evaluations: utility or futility?
    Anderson R
    Health Econ; 2010 Mar; 19(3):350-64. PubMed ID: 19378354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using economic evidence in clinical practice.
    Stone PW
    J Med Pract Manage; 2002; 17(5):272-7. PubMed ID: 12024866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.